Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study

被引:86
作者
de Graaf, R
Bijl, RV
ten Have, M
Beekman, ATF
Vollebergh, WAM
机构
[1] Netherlands Inst Mental Hlth & Addict, NL-3521 VS Utrecht, Netherlands
[2] Minist Justice, Res & Documentat Ctr, WODC, The Hague, Netherlands
关键词
comorbidity; psychiatric disorders; determinants; longitudinal;
D O I
10.1016/j.jad.2004.03.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: To describe transitions to comorbidity within a 3-year period in three cohorts of subjects with at baseline a 12-month pure mood, anxiety or substance use disorder but no lifetime history of any other disorder category. To assess the role of personal and social vulnerability factors, life events, clinical factors and functional disability in the pathway to comorbidity. Methods: Data were derived from the Netherlands Mental Health Survey and Incidence Study (NEMESIS), a prospective epidemiologic study of a representative sample of 7076 adults aged 18-65, interviewed in three waves (baseline, I and 3 years after baseline) with the Composite International Diagnostic Interview. Results: 15.2% of 99 pure mood, 10.5% of 220 anxiety and 6.8% of 192 substance use disorder cases became comorbid. Comorbid transition from pure mood disorder was multivariately associated with higher age, external mastery and severity of the disorder. Comorbidity developing from pure anxiety disorder was associated with past and recent stressful life circumstances (childhood trauma, negative life events) and physical functional disability. Predictors of comorbid transition from pure substance use disorder were personal and social vulnerability variables only (high neuroticism, low social support). Limitations: Although NEMESIS was performed among a substantial number of cases, the number of cases with a pure disorder at baseline subsequently developing comorbidity was low. This limited analysing determinants of different comorbid conditions. Conclusions: Risk factors for comorbid transitions vary depending on whether subjects have a primary mood, anxiety or substance use disorder. Interventions aimed at primary prevention of comorbidity to reduce psychiatric burden in populations with a history of pure disorders are indicated in response to clearly identified risk factors. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:461 / 467
页数:7
相关论文
共 36 条
[1]   LIFETIME COMORBIDITY OF PANIC ATTACKS AND MAJOR DEPRESSION IN A POPULATION-BASED STUDY - SYMPTOM PROFILES [J].
ANDRADE, L ;
EATON, WW ;
CHILCOAT, H .
BRITISH JOURNAL OF PSYCHIATRY, 1994, 165 :363-369
[2]  
ANGST J, 1990, COMORBIDITY OF MOOD AND ANXIETY DISORDERS, P123
[3]   The Netherlands Mental Health Survey and Incidence Study (NEMESIS): objectives and design [J].
Bijl, RV ;
van Zessen, G ;
Ravelli, A ;
de Rijk, C ;
Langendoen, Y .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 1998, 33 (12) :581-586
[4]   Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS) [J].
Bijl, RV ;
Ravelli, A ;
van Zessen, G .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 1998, 33 (12) :587-595
[5]   Current and residual functional disability associated with psychopathology: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS) [J].
Bijl, RV ;
Ravelli, A .
PSYCHOLOGICAL MEDICINE, 2000, 30 (03) :657-668
[6]   Psychiatric morbidity, service use, and need for care in the general population: Results of the Netherlands Mental Health Survey and Incidence Study [J].
Bijl, RV ;
Ravelli, A .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (04) :602-607
[7]   Psychiatric and sociodemographic predictors of attrition in a longitudinal study - The Netherlands Mental Health Survey and Incidence Study (NEMESIS) [J].
de Graaf, R ;
Bijl, RV ;
Smit, F ;
Ravelli, A ;
Vollebergh, WAM .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2000, 152 (11) :1039-1047
[8]   Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders - Findings from the Netherlands Mental Health Survey and Incidence Study [J].
de Graaf, R ;
Bijl, RV ;
Spijker, J ;
Beekman, ATF ;
Vollebergh, WAM .
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2003, 38 (01) :1-11
[9]   Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: Findings from the Netherlands Mental Health Survey and Incidence Study [J].
de Graaf, R ;
Bijl, RV ;
Smith, F ;
Vollebergh, WAM ;
Spijker, J .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (04) :620-629
[10]  
DEGRAAF R, 2000, RESPONSE NONRESPONSE